Top Back to top

Global Committee

Global Committee EBMT

As of 2018, 43 years after it was founded, the EBMT comprises 650 teams over 55 countries, and it has greatly expanded its scope outside Europe. More than 38,000 transplants are reported to the Registry each year and it has become an international reference for scientific evaluations, guidelines, studies, and education in the field of cell therapy. EBMT also is responsible for the JACIE (Joint Accreditation Committee ISCT-EBMT) program all over the world.

Many young investigators and research fellows from non-European countries trained in the early days in EBMT centres. 

Recently, young Chinese investigators and nurses have worked at the EBMT Paris office and produced pioneering studies comparing the results of Chinese and European new transplant technologies.

China, India, Korea, Vietnam, and other countries in Asia have built modern transplant units and create or join other friendly scientific structures such as the Asian Pacific Blood and Marrow Transplantation group (APBMT).

Latin America has been so far underrepresented within EBMT, though its stem cell transplantation activity has considerably increased over the last twenty years.

It is now largely well established that academic prospective clinical trials aimed at acquiring scientific knowledge form a key part of patient-oriented clinical research, and create the basis for continuously improving patient care.

The EBMT board which convened on October 22, 2016, in Barcelona, decided to create this Global Committee to favour and welcome colleagues and teams from outside Europe to extend our common experience and skills.

Global Committee Team

Committee Objectives

  • Promote the EBMT mission outside Europe, starting with Asia, i.e. particularly China, India, Korea, Vietnam. Increase European knowledge from this experience thus far not included in the EBMT megafile, and likewise share the European experience with new joining team members.
  • Increase the recruitment of EBMT teams and the numbers of transplants reported to the Registry. Enlarge the database.
  • Translate into all languages (Mandarin in China, as an example) the items in use in the EBMT collection and analysis software
  • Promote comparisons of transplant methodologies
  • Reactivate centre effect studies that would benefit from the addition of new teams with different therapeutic approaches
  • Expand targets for educational meetings  
  • Promote EBMT and its member teams (current and new members) through joint scientific meetings
  • Increase the exchanges with young investigators and PI for retrospective studies
  • Promote the exchange of nurses specialised in stem cell transplantation
  • Propose JACIE program worldwide


  • Organisation of the Global Committee annual or biannual meeting with worldwide members of the committee to define actions, policy and evaluate results of previous actions.
  • Monitoring of membership outside Europe, and specifically in Asia, for the year 2017
  • Ensure compatibility between registries (EBMT and national registries)
  • Further the development of joint meetings bringing together European and non-European teams, with a specific focus in 2018 on Asian and Latin American teams
  • Annual report to the Board


In view of the growing cooperation between many Chinese and European teams and also in view of our 2018 congress in Lisbon with a record participation from Latin America, the EBMT Global Committee has decided to focus first on Asia and Latin America.

EBMT aims to federate all transplant teams willing to share and increase experience in cell therapy today and tomorrow.

Subcommittees & Members

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to